Mrv1718004261821442D 16 16 0 0 0 0 999 V2000 -0.3764 0.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3764 -0.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3764 -0.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0873 -0.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0873 0.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3764 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7984 0.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5094 0.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2624 0.8365 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.5094 -0.4182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.9734 0.4182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0875 -0.8364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7986 -0.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5514 -0.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2625 -0.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9734 -0.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7 8 1 0 0 0 0 2 3 2 0 0 0 0 8 9 1 0 0 0 0 3 4 1 0 0 0 0 8 10 2 0 0 0 0 4 5 2 0 0 0 0 9 11 1 0 0 0 0 5 6 1 0 0 0 0 2 12 1 0 0 0 0 6 1 2 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 5 7 1 0 0 0 0 14 15 1 0 0 0 0 1 2 1 0 0 0 0 15 16 1 0 0 0 0 M END > DB13346 > drugbank > CCCCOC1=CC=C(CC(=O)NO)C=C1 > InChI=1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14) > MXJWRABVEGLYDG-UHFFFAOYSA-N > C12H17NO3 > 223.272 > 223.120843411 > 3 > 33 > 24.582917439231654 > 1 > 2 > 0 > 1 > 2-(4-butoxyphenyl)-N-hydroxyacetamide > 2.09 > 1.9670975133333335 > -2.98 > 0 > 1 > 0 > 17.164112723240702 > 8.859258213503633 > -4.840325433523242 > 58.56 > 61.2892 > 6 > 1 > 2.33e-01 g/l > bufexamic acid > 0 > DB13346 > approved; withdrawn > Bufexamac > 2-(p-Butoxyphenyl)-acetohydroxamic acid; 4-Butoxy-N-hydroxybenzeneacetamide; 4-Butoxyphenylacetohydroxamic acid; Acide p-butoxyphenylacethydroxamique; Bufexamac; bufexamaco; bufexamacum; Bufexamic acid; p-Butoxyphenylacetohydroxamic acid > Norfemac Cream - 5%; Norfemac Ointment - 5% $$$$